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Since their initial discovery in 1976, mesenchymal stem cells (MSCs) have been
gathering interest as a possible tool to further the development and enhancement of
various therapeutics within regenerative medicine. However, our current understanding
of both metabolic function and existing differences within the varying cell lineages (e.g.,
cells in either osteogenesis or adipogenesis) is severely lacking making it more difficult to
fully realize the therapeutic potential of MSCs. Here, we reconstruct the MSC metabolic
network to understand the activity of various metabolic pathways and compare their
usage under different conditions and use these models to perform experimental design.
We present three new genome-scale metabolic models (GEMs) each representing a
different MSC lineage (proliferation, osteogenesis, and adipogenesis) that are biologically
feasible and have distinctive cell lineage characteristics that can be used to explore
metabolic function and increase our understanding of these phenotypes. We present
the most distinctive differences between these lineages when it comes to enriched
metabolic subsystems and propose a possible osteogenic enhancer. Taken together, we
hope these mechanistic models will aid in the understanding and therapeutic potential
of MSCs.
Keywords: GEM, MSCs, osteogenesis, metabolic reconstruction, adipogenesis, metabolic differences
INTRODUCTION
Mesenchymal stem cells (MSCs) originate in the mesenchymal germ layer of the embryo and can
be isolated from various adult tissues, including bone marrow, adipose tissue and skeletal tissue
to name a few. In vitro MSCs are a heterogeneous population of cells that can be expanded and
differentiated to chondrocyte, adipocyte and osteocyte lineages (Liu et al., 2006). MSCs have been
used as tissue replacements with mixed results but recent studies suggest that their paracrine effect
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may be of greater clinical importance (Rosenbaum et al., 2008;
Duijvestein et al., 2010; Mohyeddin Bonab et al., 2012; Campana
et al., 2014; Goldberg et al., 2017; Sigmarsdóttir et al., 2020).
The differentiation of MSCs is characterized by chemical and
mechanical signals (such as changes to available metabolites,
Croitoru-Lamoury et al., 2011; Buravkova et al., 2013) and
changing metabolic capabilities (Chen et al., 2008).
This study focuses on MSCs during expansion, early
osteogenesis and early adipogenesis because of the potential
utility of the cells as immune-modulators (Aggarwal and
Pittenger, 2005; Gan et al., 2008; Waterman et al., 2010; Neman
et al., 2012; Valencia et al., 2016; Wang et al., 2018; de Castro
et al., 2019) and the intricate inverse relationship that seems to
exist between adipogenesis and osteogenesis. Osteoporosis is a
common and sometimes a severe age related disease condition
that can go on undiagnosed until a major fracture occurs.
“Malfunctioning” of MSCs in osteoporosis pushes cells toward
adipose accretion in the bone marrow at the expense of osteoblast
formation – indicating that under this condition MSC behavior
is altered and the microenvironment disturbed. A similar shift
has been observed to happen under microgravity conditions, as
are seen during space flights (Zayzafoon et al., 2004; Pino et al.,
2012; Phetfong et al., 2016; Han et al., 2019). Understanding
metabolic aspects of this shift may aid in preventing it. Moreover,
understanding metabolic differences between MSCs in expansion
and in osteogenic differentiation will allow optimization of
in vitro expansion and initial in vitro osteogenic differentiation
of MSCs needed for therapeutic techniques to succeed.
Over the past decade as the rate of biological data
generation has increased, data analysis and interpretation has
become a bottleneck of biological discovery (Yurkovich and
Palsson, 2016), necessitating improved modeling and analysis
approaches to organize and interpret data (Becker et al.,
2007; Thiele and Palsson, 2010; Noronha et al., 2018). By
creating a framework to integrate multiple data types (e.g.,
metabolomics, transcriptomics, proteomics, and genomics),
genome scale metabolic models (GEMs) provide a more nuanced
understanding of how the cell achieves a given metabolic state
(Oberhardt et al., 2009; Thiele and Palsson, 2010; Aurich et al.,
2015, 2016; Yurkovich and Palsson, 2016) that can be further
tailored to specific physiological conditions using a variety of
constraint-based reconstruction and analysis (COBRA) methods
(Becker et al., 2007; Orth et al., 2010; Heirendt et al., 2019).
Genome scale metabolic models have been applied to various
biological problems including drug resistance and biomarker
identification and have been explored using these approaches
(Oberhardt et al., 2009; Motamedian et al., 2015; Väremo et al.,
2015). Previously, a GEM of MSC metabolism (iMSC1255) was
developed (Fouladiha et al., 2015) and used to assess the effects
of metabolic environmental changes on chondrogenesis and
proliferation (Fouladiha et al., 2018). However, iMSC1255 is
limited by only including transcriptomic data from proliferating
MSCs and has not considered osteogenesis or adipogenesis
explicitly. Furthermore iMSC1255 was based on Recon1 (Duarte
et al., 2007), a base human metabolic reconstruction that
has been superseded by Recon3 (Brunk et al., 2018). Recon3
includes greater detail of lipid metabolism and glycan metabolism
that are known to be key to the processes of differentiation
that these models will be used to study. To provide an
improved modeling framework to study MSC osteogenic and
adipogenic differentiation this paper describes a new set
of three models that separately describe the metabolism of
expanding MSCs (iMSC_E_1972), osteogenically differentiating
MSCs (iMSC_O_1900), and adipogenically differentiating MSCs
(iMSC_A_2036). These models provide improved metabolic
coverage by using an updated base model from Recon3
(Brunk et al., 2018). The new models were constructed with
publicly available lineage specific transcriptomic data, and new
metabolomics data produced in house from each lineage. By
creating this set of equivalent but separate models, it is possible
to create an in silico laboratory that helps to design experiments
for the cell culture laboratory with a higher probability of success.
Here, we describe three parallel GEMs of MSC metabolism:
during expansion, iMSC-E-1972; osteogenic differentiation,
iMSC-O-1900; and adipogenic differentiation, iMSC-A-2036.
We have benchmarked these models against generic human
metabolic functions, the existing model of MSC metabolism,
iMSC1255, and known metabolic differences between lineages.
We then used these benchmarked models to propose ideas for
optimizing osteogenic differentiation of MSCs that will hopefully




Transcriptomic data were obtained from ArrayExpress
(Kolesnikov et al., 2015). Data sets were selected based on
their relevance to the experimental conditions described below
for collection of uptake and secretion data. The most important
considerations having been lineage of differentiation and the
length of time since the start of differentiation (7 days). See
Table 1 for details of the data sets.
The selected data sets were processed using MATLAB
(Mathworks, Natick, Massachusetts, United States). First, the data
set IDs were converted to Entrez IDs using either DAVID (Huang
et al., 2009; Agarwala et al., 2018) or the chip data from array
expression in combination with MATLAB. These numbers were
then normalized within each data set and re-scaled so that the
magnitude of the range of expression values was like the starting
range (all the data sets had maximal expression values of around
1000 to begin with and this range was approximately maintained)
allowing the data to be pooled.
Metabolic Data Collection
Mesenchymal stem cells were obtained from 5 to 6 different
donors from LONZA (Basel, Switzerland, donors with National
Bioethics committee number VSN19-189). Cells were stored in
liquid nitrogen, thawed and seeded in 175cm2 flask in basal
medium in an incubator at 5% CO2, 37◦C and 95% humidity. For
experiments cells were seeded in 75cm2 flasks at 6000cells/cm2.
Cells were either grown in basal growth medium or osteogenic
differentiation medium. 5000 IU/ml of heparin (LEO Pharma
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TABLE 1 | List of data sets used to create the computational models.
# of set iMSC-E-1972 iMSC-O-1900 iMSC-A-2036
1 Samples and Data < E-MEXP-3046
< Browse < ArrayExpress <
EMBL-EBI, 2018
Samples and Data < E-MEXP-3046





Matching “ ‘Mesenchymal Stem
Cell’
” < ArrayExpress < EMBL-EBI,”
n.d.; Ng et al., 2008)
E-TABM-(“E-TABM-
318 < Experiments Matching “
‘Mesenchymal Stem Cell’
” < ArrayExpress < EMBL-EBI,”
n.d.; Ng et al., 2008)
3 E-TABM-318 NA NA
A/Sm Ballerup, Denmark), 1% Penicillin/Streptomycin (Gibco,
Grand Island, NY, United States), and 10% Platelet lysate
(Platome Reykjavik, Iceland) into DMEM/F12 + Glutamax
growth medium (Gibco, Grand Island, NY, United States). This
mixture will hereby be referred to as the basal growth-medium.
The platelet lysate (PIPL) was centrifuged at 5000rpm/4975g for
ten minutes before the supernatant being added to the medium
to remove platelet debris and coagulation. The differentiation
medium also with the addition of dexamethasone (50 µl,
Sigma, Missouri, SL, United States), BMP-2 (50 µl, Peprotech,
Rocky Hill, United States), β-glycerophosphate (108 mg, Sigma,
Missouri, SL, United States), and ascorbic acid (50 µl, Sigma,
Missouri, SL, United States). Cells were used between passage 2
and 6 and care was taken to ensure that at least 5 of the same
donors were used for each lineage. Medium was changed on
average every 48 h.
Baseline and spent medium samples were assayed
for glucose and lactate concentration using an ABL90
blood gas analyzer (Radiometer Medical ApS, Bronshøj,
Denmark). In addition, medium samples were analyzed by
high pressure liquid chromatography mass spectrometry as
described below.
Cell number was determined by trypan blue exclusion and
counting in a hemocytometer and an approximate doubling
time calculated, this was confirmed with estimates from the
literature (Milo et al., 2010). An estimate of dry cell weight
was obtained from the literature (Milo et al., 2010) and the
changes in metabolite concentration per hour per gram of dry
weight were calculated using linear regression in MATLAB. The
resulting estimates of uptake and secretion rate of the measured
metabolites were applied as constraints to the metabolic model as
described below.
Mass Spectrometry
UPLC-MS Analyses were performed with an UPLC system
(UPLC Acquity, Waters, MA, United Kingdom) coupled in
line with a quadrupole-time of flight hybrid mass spectrometer
(Synapt G2, Waters, MA, United Kingdom) as described in Paglia
et al. (2012).
Model Construction
Model construction was performed using the Constraint-based
reconstruction and analysis (COBRA) Toolbox version 3 in
MATLAB, 2017b (Mathworks, Natick, MA, United States).
The GEM Recon3 (Brunk et al., 2018) was used as a
base reconstruction of the global human metabolic network.
We further modified the model to more closely represent
MSC metabolism (e.g., extracellular bile acid metabolism and
drug metabolism) and to include a greater range of glycan
metabolism and lipid metabolism (see Supplementary Table 1).
The version of Recon3 downloaded from VMH.life (Virtual
Metabolic Human n.d.) had already been constrained to be
thermodynamically feasible. We used standard quality checks
from the COBRA Toolbox (Thiele and Fleming, n.d.) to ensure
that the model remained mathematically and biologically feasible
as transcriptomic data were integrated.
We constrained the base model using known medium
composition, the list of additional metabolites detected by mass
spectrometry in basal medium, and data on cell weight and
growth using the Metabotools suite within the COBRA Toolbox
(Heirendt et al., 2019). This was done separately for proliferating
and osteogenically and adipogenically differentiating MSCs.
These three media-constrained models were further constrained
using the transcriptomic data described above with core
reactions those considered important based on the literature (see
Supplementary Table 2) increased to maximal expression and
the GIMME algorithm implemented in the COBRA Toolbox
(Becker and Palsson, 2008). GIMME was selected as it retains
the model growth function. This was considered appropriate
because during the process of expansion and the initial stages of
differentiation modeled here, MSCs are growing. It was ensured
that these models remained mathematically and biologically
feasible and that core reactions were all included. Those
core reactions that were not included were manually added
along with reactions to link them into the model. These
transcriptomically constrained models then had uptake and
secretion constraints added based on mass spectrometry data
with minimal relaxation of these added constraints to allow
a feasible model (the list of rates can be found in Method
labeled Supplementary Data Sheet, see Rxn_fluxes_for_O_model,
Rxn_fluxes_for_E_model, and Rxn_fluxes_for_A_model). Finally,
these models were pruned to give fully functional condition
specific models. The models were then checked for the inclusion
of core reactions and biological feasibility. We validated the three
new reconstructions against the original Recon3 model using
Memote (Lieven et al., 2020).
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The model iMSC1255 was downloaded (Fouladiha et al.,
2015) and used for comparison, for some comparisons the
constraints on uptake and secretion of metabolites were altered
to create three models; expansion, osteogenic differentiation and
adipogenic differentiation.
Model Comparison
Lethal genes and reactions - those essential to produce flux
through the biomass reaction - were determined for each model
using the relevant functions in the COBRA Toolbox. Random
sampling of the solution space for between 50 and 100% of the
optimal biomass reaction flux using the “gpSampler” function
in the COBRA Toolbox (Schellenberger and Palsson, 2009), in
combination with flux variability analysis (FVA) (Gudmundsson
and Thiele, 2010) and flux balance analysis (FBA) (Orth
et al., 2010) with the biomass function as the objective were
used to determine, the range, probability of distribution, and
optimal fluxes through all the model reactions in each model.
These were all performed in the COBRA Toolbox. To explore
possible reactions needed to optimize osteogenesis the relax
reactions function was used. Intersect models including the
reactions of either osteogenesis and expansion or osteogenesis
and adipogenesis were created, the mean random sampled fluxes
for the osteogenic model (with zeros for reactions not in that
model) were assigned as the target state and the intersect model
with expansion or adipogenic bounds was used as the initial state.
An alpha 0.99 was used except where this gave only over 100
reactions to relax, in which case 0.75 was used to achieve lists
of reactions to relax that were of a length that could be easily
explored. Results from these analyses were assessed by subsystem
and gene rule using flux enrichment analysis in the COBRA
Toolbox in MATLAB.
RESULTS
Three comparable models of MSC metabolism representing
expansion, osteogenesis and adipogenesis were built using
publicly available transcriptomic data and parameterized with
newly generated metabolomic data. It was shown that these
models could recapitulate known metabolic differences among
the three cell subtypes and that has allowed the proposal of
novel interventions to optimize osteogenesis that will guide
future investigations.
Metabolomics Data Analysis Indicates
Functional Difference
In order to parameterize the three models of MSC differentiation
extracellular metabolomic data (UPLC-MS) was generated for
each cell lineage. The estimates of uptake and secretion rate
of the measured metabolites were applied as constraints to the
metabolic model, enabling them to be analyzed in the context
of previously published data on metabolic network structure
as summarized in Recon 3 (add in relevant reference), and
MSC transcripts from cells at the relevant stage and lineage of
differentiation (add in references for the array express data sets).
A total of 59 unique metabolites were detected across the three
cell culture lineages. Of these metabolites, 42 were detected in the
expansion samples, 50 were detected in the osteogenic samples,
and 44 were detected in the adipogenic samples. Interestingly,
some metabolites showed opposite trends in the different cell
lineages. For example, asparagine, folate, and fumarate were
taken up only in expanding cells. Ascorbate, aspartate (measured
only in O), glycerol 2 phosphate, glycl groups, palmitate,
histidine, pantothenate, proline and threonine (only measurable
in O) were taken up only in osteogenic cells. Oxoproline,
acetyl carnitine, adenine, adenosine, biotin, phosphocholine,
guanine, phenylalanine, riboflavin, and spermine were taken
up only in adipogenic cells (rate lists can be found in
Supplementary Material). These data were analyzed by applying
them as constraints to the prior knowledge contained in
metabolic networks based on Recon 3 and previously published
transcriptomics data. This allowed us to leverage prior knowledge
to gain greater insights into the likely metabolic changes to
MSCs during differentiation than would have been obtained by
statistical methods.
Newly Reconstructed Models Expand
Coverage of Metabolic Pathways and
Accurately Represent Core Metabolic
Fluxes
Model reconstruction is an iterative process where multiple
type of -omic data are combined and results from experiments
based on model predictions are used to make future predictions
more accurate (Figure 1). As shown in Table 2 the three
models were of similar size with a mean of 6517 reactions,
3674 metabolites and 1969 genes, an increase in size of almost
3-fold compared iMSC1255 (2288 reactions, 1850 metabolites,
and 1259 genes). The three models had a combined total of
7478 unique reactions, of which 212 reactions were unique
to iMSC-E-1972, 151 reactions were unique to iMSC-O-1900,
and 457 reactions were unique to iMSC-A-2036. The ability to
produce extracellular calcium phosphate—an important function
for osteogenic MSCs—was added to the osteogenic model.
iMSC-O-1900 contained fewer genes, reactions and
metabolites compared to the other two final models, a difference
first apparent after implementing the transcriptomic constraint.
The base model, adapted from Recon3D, and the three new
iMSC models were assessed using the memote tool (Lieven et al.,
2020). The iMSC1255 (Fouladiha et al., 2015) scored 31% overall.
This reflected high scores for model consistency but low scores
on annotation. iMSC-E-1972 scored 37%, iMSC-O-1900 48% and
iMSC-A-2036. Again scores were higher for consistency than
annotation, however, annotation was improved. All of the new
models include around 2100 stoichiometrically balanced cycles,
however, given the size of the models this was unsurprising.
The models do not erroneously produce ATP, NAD, or NADP
(threshold 1e-10) and a fast leak test from the Cobratoolbox
found no leaking metabolites.
None of the newly constructed MSC models showed
biologically infeasible behaviors such as creating ATP from water
alone or leaking metabolites when uptake was prevented (see
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FIGURE 1 | A schematic drawing showing how metabolic modeling can integrate data to contribute to planning future experiments and potential utilization. Stage (i)
Initial metabolomics and transcriptomics data acquisition from in vitro culture. Stage (ii) Statistical analysis of metabolomic and transcriptomic data. Stage (iii)
Reconstruction of the human metabolic network from the literature and previous knowledge. Stage (iv) Application of metabolic and transcriptomic data to the
metabolic network to produce context specific models. Stage (v) Analysis of the differences between the three biological models. Stage (vi) Verification of novel
findings of the models initially through comparison to the results of published experiments (presented in this manuscript) and then through new experiments. Stage
(vii) Improved knowledge of the biological system enabling optimized growth and differentiation that may be applied to improve healthcare or industrial outcomes.
Supplementary Table 1). It should be noted that the previously
published iMSC1255 generally also fulfilled these criteria but does
include some duplicated reactions, possibly due to the treatment
of reversible reactions.
The three new MSC models presented here were all capable of
producing approximately the correct number of ATP molecules
per molecule of both glucose (32 aerobic and 2 anaerobic for
all three models) and glutamine (22.5 aerobic and 1 anaerobic
all three models) under both aerobic and anaerobic conditions.
There were slight differences in theoretical ATP production
in the literature and existing models but around 31 from
aerobic glucose, 2 from anaerobic glucose, 23 from aerobic
glutamine and anaerobic glutamine are common figures obtained
in other models including those specifically curated for central
energy metabolism (Smith et al., 2017; Mazat and Ransac,
2019). However, the estimates of these values for iMSC1255
were often very different (423 glucose aerobic, 400 glucose
anaerobic, 415 glutamine aerobic, and 399 glutamine anaerobic).
These large values for ATP production from glucose and
glutamine in iMSC1255 were explained by increased activity
in the mitochondrial ATPsynthase reaction. The presented new
and updated models therefore better captured the energetics of
central carbon, fatty acid, and amino acid metabolism.
ATP production from other important carbon sources was
also generally close to theoretical values (see Figure 2) in the
three new MSC models. The initial values for medium fatty acid
composition had a large effect on these values and the differences
are likely due to the composition chosen.
The uptake and secretion fluxes of amino acids in the
proliferation model and the original iMSC1255 values were
compared (see Supplementary Table 2 for details). Nine of the
amino acids with uptake/secretion values reported in Fouladiha
et al. (2015) were included in the constraints for our model based
on our own measurements. These were generally in accordance
with the reported constraints. Leucine and lysine fluxes were
not based on mass spectrometry measurements, but the range
of random sampled fluxes falls at least partially within the
same range as the iMSC1255 estimates. Another six amino acids
had fluxes in the same predicted direction as iMSC1255 but
overestimated the magnitude of uptake or secretion. Two amino
acids are predicted as secreted in our random sampling but
taken up by iMSC1255.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 June 2021 | Volume 9 | Article 642681
fcell-09-642681 May 31, 2021 Time: 18:23 # 6
Sigmarsdottir et al. Metabolic Reconstruction in MSC Differentiation
FIGURE 2 | Estimates of optimal fluxes for ATP production from various key carbon sources – (A) Aerobic metabolism of the most energy dense substrates
(B) Aerobic metabolism of the least energy dense substrates (C) Anaerobic metabolism.
Mitochondrial Function Separates
Proliferating and Differentiating MSCs
and Pentose Phosphate Pathway Flux
Differentiates Osteogenesis and
Adipogenesis
To determine the quality of the models, model predictions were
compared to data about MSC metabolism from the literature.
Proliferating, osteogenically and adipogenically differentiating
bone marrow derived MSC models were examined and compared
to the outputs from the re-constrained versions of iMSC1255
(Fouladiha et al., 2015). The newly produced models matched the
data very well for the relative levels of beta hydroxylase activity,
but iMSC1255 does not include beta hydroxylase reactions. The
new models qualitatively predicted differences in flux between
TABLE 2 | Model size at various stages of construction (E) refers to iMSC-E-1972,
(O) refers to iMSC-O-1900, and (A) refers to the iMSC-A-2036.
Model Genes Reactions Metabolites
Recon3D 3697 13543 8399
Base Model 2280 9151 4900



























iMSC1255 model (used for
comparison)
1259 (E) 2288 (E) 1850 (E)
proliferating MSCs and one or other of the differentiating
lineages but not both in lactate dehydrogenase, creatine kinase,
glyceraldyhyde-3-phosphate dehydrogenase, phosphofructokinase
and glutathione reductase with only a slight mis-estimation
in the other differentiation lineage. iMSC1255 estimated very
similar fluxes across all three models for all of these reactions.
Isocitrate dehydrogenase appeared to be well estimated in the
adipogenic and proliferation models but underestimated in
the osteogenic model, iMSC1255 estimated little difference
in this reaction.
Various studies have analyzed metabolism in osteogenic
and adipogenic differentiation of cells, sometimes in MSCs
and sometimes in other cell types (Pattappa et al., 2011;
Meleshina et al., 2016; Shum et al., 2016). The new models
were compared to several of these studies. Random sampling
of the new models with a flux of between 50 and 100% of the
biomass function showed that both iMSC-O-1900 and iMSC-A-
2036 show increased flux through mitochondrial ATPsynthase,
marked as highly significant using the Wilcoxon statistic in
MATLAB (ranksum, p-Values ∼0 for O vs. E and 5.40 e-81 for
E vs. A). Both differentiating models had mean predicted values
twice as high as the proliferating model. The minimum values
for the iMSC-A and –O were around ten times than in iMSC-
E. However, the maximum value in iMSC-E was approximately
10% higher than either differentiating model, indicating that
differentiating models showed increased mitochondrial function
(Figure 3A). It has also been reported that suppression of
ornithine decarboxylase activity increases osteogenesis in human
bone marrow MSCs (Tsai et al., 2015). This is supported by the
mean flux from random sampling iMSC-E-1972 for ORNDC
being greater over 10 times greater than the value of that in
iMSC-O-1900 (Figure 3B, p∼ 0 Wilcoxon rank test).
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FIGURE 3 | Relative mean fluxes (compared to expansion model) from various reactions – (A) ATPsynthase (B) Ornithine decarboxylase (C) Mitochondrial
glutaminase (D) NAD dependent glutamate dehydrogenase (E) NADP dependent glutamate dehydrogenase.
Conversely, it has been shown that suppressing glutaminase
activity and the contribution of glutamine to the TCA
cycle prevents osteogenesis (Huang et al., 2017; Chen et al.,
2019). iMSC-O-1900 showed lower mitochondrial glutaminase
(Figure 3C) but higher cytoplasmic glutaminase (not seen in
iMSC-E-1972) and overall glutaminase activity more than twice
as high as the proliferation model. However, the contribution
of glutamine to the TCA cycle via glutamate dehydrogenase
(anaplerosis) was slightly higher in the proliferation than the
osteogenic model (Figures 3D,E). Other uses of glutamate
account for the rest of the osteogenic model’s glutaminase
activity. This result indicates that this central area of metabolism
may be lacking in sub-cellular location specificity in the
models, however, it substantially agrees with the literature
on a whole cell basis. Furthermore, it has been shown that
the production of kyneurine via indoalamine dioxygenase
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is increased in osteogenesis compared to proliferation of
MSCs (Vidal et al., 2015). A key enzyme in this pathway
L-Tryptophan:Oxygen 2, 3-Oxidoreductase (Decyclizing), that
produces L formyl-kyneurine is absent from iMSC-E-1972 but
present in iMSC-O-1900 (and iMSC-A-2036).
A key feature of adipogenesis is the upregulation of
glucose 6 phosphate dehydrogenase activity. G6PDH forms
6-Phosphonoglucono-D-lactone (6PGL) and NADPH. 6PGL
contributes to the pentose phosphate pathway and therefore the
production of nucleotides and reducing potential via NAPDH.
NADPH contributes to the synthesis of fatty acids by supplying a
reducing agent. This is a key metabolic coupling between glucose
and fatty acid utilization and storage (Park et al., 2005). Overall,
the formation of NADPH by this reaction was much higher in
iMSC-A-2036, around ten times higher than iMSC-E and almost
twice that of iMSC-O (Figure 4D). This was partially due to the
higher endoplasmic reticulum G6PDH forward activity in iMSC-
A-2036 but also due to the presence of some reverse activity being
predicted in iMSC-O-1900 and -E-1972.
To assess metabolic differences between MSCs undergoing
expansion, osteogenic differentiation, and adipogenic
differentiation, Markov chain Monte Carlo (MCMC,
Schellenberg et al., 1992) sampling was used to generate a
uniform random sampling of the solution space of each of the
three the models. A set of predictions for each reaction was
obtained and these sets of predictions compared across the
three models. Specifically, the fold changes in the means for
each reaction were compared, 5-fold change being considered
FIGURE 4 | Comparison of relative magnitude of metabolic fluxes found at day 7 of expansion, osteogenic and adipogenic differentiation in Meyer et al. (2018),
iMSC1255 er-constrained with MS data collected in Iceland and the new models (A) Phosphofructokinase (B) Glyceraldyhyde 3 phosphate dehydrogenase
(C) Lactate dehydrogenase (D) Glucose 6 phosphate dehydrogenase (E) Isocitrate dehydrogenase (F) Glutathione reductase (G) Creatine kinase (H) Beta hydroxyl
acyl dehydrogenase. E, Expansion; O, Osteogenesis; A, Adipogenesis.
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of interest, and a two tailed t-test was performed using 1e-12
as a p-Value cut-off; see Metabolic_difference_rxn_pred in
Supplementary Data Sheet for a full list of these reactions.
Reactions in the model were grouped by metabolic subsystem
enabling an enrichment analysis to be performed on lists of up
regulated reactions (predicted to carry more flux) in each cell type
compared to each of the others, shown in Table 3. Enrichment
analysis compares which subsytems (areas of metabolism) show
more reactions that are up regulated compared to the expected
distribution of changes if all changes occurred by chance across
the whole of metabolism. This demonstrates those areas of
metabolism that are more important to one lineage than another.
This enrichment analysis showed that the areas of metabolism
that are significantly more active in proliferating cells than in
either of the differentiating cell types include biotin metabolism,
vitamin A metabolism, sphingolipid metabolism, fatty acid
oxidation and fatty acid synthesis as well as mitochondrial
transport and exchange/demand reactions. This upregulation
showed higher activity in areas of metabolism related to fatty
acid signaling (vitamin A and sphingolipids). Sphingolipid
metabolism may also indicate the need for new cell membranes.
In adipogenic differentiation, fatty acid oxidation and as would be
expected fatty acid synthesis were over represented in increased
activity along with exchange/demand reactions. Fatty acid
oxidation and exchange demand reactions were over represented
in increased activity reactions in osteogenesis compared to the
other pathways studied, see Figure 5.
Model-Driven Experimental Design for
Engineering Osteogenesis
Metabolic modeling allows the generation of hypotheses
about means of optimizing one cell lineage over another.
To propose means of improving osteogenesis desirable for
regenerative medicine, combined models of either expansion-
and-osteogenesis or adipogenesis-and-osteogenesis were created.
Two of each of these models were produced, one representing the
constraints on reactions from each lineage with other reactions
blocked. These models were then subjected to relaxation analyses.
The results of relaxing the model to find a solution
intermediate between either the expansion model or the
adipogenic model and the osteogenic model produced lists
of key reactions to modify to move towards osteogenesis (see
Relaxed_rxn_lists, Supplementary Data Sheet, for the more
extensive lists required for full transition). The transport
reactions to relax to move from expansion to osteogenesis
were transport from extracellular to cytosol of serotonin,
urea and 13-Docosenoic Acid, in all case the changes moved
these metabolites from being taken up to being either not
active or in the case of 13-Docosenoic Acid to being secreted.
To transform from adipogenic to osteogenic by modifying
transport reactions Bilirubin Beta-Diglucuronide uptake
should be prevented along with the blocking of leukotriene
C4 reduced glutathione transport, thromboxane B2 transport,
leukotriene E4 transport and Mono (Glucosyluronic Acid)
Bilirubin transport while inward transport of citrate and
ribosomal transport of bilirubin should be encouraged. The
TABLE 3 | Showing subsystems that have a significantly overrepresented
(adjusted p-value < 0.05) number of more active reactions in the relevant model
compared to the other differentiation lineage in the case of








0.000254 98 1368 Exchange/demand reaction
0.001831 65 961 Fatty acid oxidation
0.003348 9 242 Cholesterol metabolism
0.003348 9 240 Fatty acid synthesis
0.003348 1 105 Transport, lysosomal
0.003348 25 453 Transport, mitochondrial
0.006098 3 133 Sphingolipid, metabolism
0.011893 7 185 Bile acid synthesis
0.017589 11 47 Vitamin A metabolism







7.09E-07 12 961 Fatty acid oxidation







1.64E-05 26 1368 Exchange/demand reaction
0.000253 16 961 Fatty acid oxidation
0.012651 1 240 Fatty acid synthesis
non-transport reactions (including demand and exchange
reactions) to alter to encourage osteogenesis from expansion
are: ’EX_cspg_e[e],’ ’KAS8,’ ’r0797,’ ’RE0344C,’ ’RE0577C,’
’RE0578C,’ ’RE1845C,’ ’EX_aicar[e],’ ’EX_gudac[e],’ ’EX_stcrn[e],’
’EX_Lhcystin[e],’ ’EX_mal_L[e],’ ’MYELIN_HSSYN,’ and
’DM_myelin_hs[c].’ These reactions include amino acid
uptake and formation of lipid and glyco lipids. The equivalent
reactions for encouraging osteogenesis from adipogenesis are:
’EX_retfa[e],’ ’EX_mal_L[e],’ ’EX_taur[e],’ and ’DM_na1[r].’
Again, this includes alterations to the necessary amino acids as
well as fatty acid retinol involved in developmental signaling.
The relaxation required of truly non-transport reactions to bring
the expansion model close to the osteogenic model are ’KAS8,’
’r0797,’ ’RE0344C,’ ’RE0577C,’ ’RE0578C,’ and ’RE1845C.’ These
reactions are all involved in fatty acid and CoA metabolism
and are generally moving from being active (sometimes in the
reverse direction) to being less active or inactive. The equivalent
relaxation (with an alpha value of 0.75) produced no necessary
changes from adipogensis to osteogenesis however with and
alpha of 0.9 ’3SALACBOXL,’ ’CBPPer,’ ’GGNG,’ ’GLBRAN,’
’GLGNS1,’ ’KAS8,’ ’LCYSTCBOXL,’ ’r0060,’ ’IDL_HSSYN,’
’IDL_HSDEG,’ ’HMR_3422,’ and ’HMR_6647.’ These reactions
become more active or move from a negative to a positive
direction while ’LPS3e,’ ’NDP7er,’ ’PCHOL2LINL_HSPLA2,’
and ’PE203_HSPLA2’ more from the reverse direction to
inactivity. Many of these reactions are glycosylating enzymes
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FIGURE 5 | Graphical representation of the enriched subsystems between the cell lineages based on the new reconstructed models – The three figures show in a
graphical manner the subsystems (a group of related metabolic reactions representing a specific aspect of metabolism) in each model that were found to contain
significantly more changed reactions than other subsystems of the model. Shown is – (A) Proliferation of MSCs, with various subsystems identified as enriched. This
mirrors expectations as expansion requires energy and synthesis of new material (e.g., cell wall and DNA). (B) Adipogenesis of MSCs, with subsystems related to
synthesis and breakdown of fatty acids identified as enriched as well as exchange/demand reactions (C) Osteogenesis of MSCs, with subsystems related to fatty
acid breakdown and TCA-cycle activity identified as enriched as well as exchange/demand reactions. For detailed list with included p-Values for each listed
subsystem see Table 3. Green arrows and labels indicate enriched pathways.
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likely accounting for the alterations in the cells’ outer glycan
layer between these two states.
DISCUSSION
The driving factor behind this study was to improve
understanding of the metabolic underpinnings of MSC
differentiation with hopes that that will enable further
application of them in regenerative medicine. To achieve that
three metabolic networks were reconstructed from varied -omics
and experimental data and compared. The models achieved to
recapitulate key metabolic phenotypic features characteristic for
each cell state, to showcase the major metabolic differences and
to propose a possible way to improve osteogenesis.
Measurements of Metabolism
The metabolomic data used in the reconstruction of the
presented models was specifically generated and analyzed in
order to parametrize the models in accordance to very specific
experimental conditions known to the authors to influence
the cells in a specific desired manner. The mass spectrometry
data shows differences in metabolism between the 3 lineages
of cells. These changes in the extracellular milieu support
different metabolism during cell growth and differentiation of
MSCs. In order to better understand how these extracellular
changes reflected intracellular metabolic changes during MSC
expansion and differentiation, these data were analyzed in the
context of changes in gene transcription within their respective
metabolic models.
Reconstruction of Metabolic Models for
Three States of MSCs
Three constraint-based models of MSC metabolism (iMSC-E-
1972, iMSC-O-1900, and iMSC-A-2036 describing expansion,
osteogenesis, and adipogenesis, respectively) were reconstructed,
from the global human metabolic network (Recon3), publicly
available transcriptomic data and metabolomic data generated
here. These models largely share reactions (2.0 - 6.1% of
total reaction number are unique to a model), an expected
result considering the transcriptomic data seem to have
had the strongest effect on inclusion/exclusion of reactions
as demonstrated by showing the biggest change in the
number of reactions included in each model (Table 2). These
transcriptomics data, and the metabolomics data, represent
MSCs at day 7 after first exposure to differentiation medium. Day
7 is still considered as an early stage of the two differentiation
processes that take between 21 and 28 days, respectively, and
increased lineage differences are expected to be seen at later
time points, however, there was insufficient data available for
those later time points in a suitable format at the time that this
project began. The publicly available transcriptomic data used to
generated these models had lower coverage of metabolic genes for
the osteogenic state, resulting in a smaller number of reactions
included in this model (iMSC-O-1900) when compared to the
other two (iMSC-E-1972 and iMSC-A-2036). The osteogenic
transcript was missing any call, present or absent for 5.19%
of base model genes whilst proliferation and adipogenesis were
missing information for only 2.35 and 2.38%, respectively.
These models can be continually upgraded and expanded using
specifically generated RNAseq data from cells collected at later
stages of osteogenesis and adipogenesis in order to further
improve the predictive capabilities of the models. The use of
RNAseq data in the place of microarray-based data is also likely
to improve the coverage of enzyme expression data.
Verification of Metabolic Function in Comparison to
iMSC1255
This comparison is in some ways limited to broad comments
as the enzyme activity assays in the paper presented by
Fouladiha et al. (2015) were performed to determine maximal
activity in cell extracts, not fluxes in living cell situations as
simulated by the models.
The new MSC models all pass key metabolic sanity checks
and manage an almost 3-fold increase in metabolic coverage
compared to iMSC1255, roughly a proportional increase to
that between the base model and Recon1. This similarity
suggests retention of similar level of cell specificity compared
to iMSC1255 despite the great increase in metabolic coverage.
However, the models reported here are able to more correctly
capture the production of ATP from various substances and are
additionally able to perform more metabolic functions compared
to the previously existing MSC model, iMSC1255 (originally
reconstructed for cells exclusively in the state of proliferation).
One of the areas of metabolic function that the models presented
in this paper are more adept at in comparison to iMSC1255
is fatty acid metabolism. This is illustrated by the example of
iMSC1255 lacking beta hydroxylase activity (Figure 4), but the
activity of beta hydroxylase has been shown to be present in
MSCs, as well as its much smaller number of human functions
assessed by the COBRA Toolbox (Supplementary Table 1).
As fatty acid metabolism is key to adipogenesis, the additional
detail of beta hydroxylase inclusion in the new presented models
will likely prove important to the utility of their predictions. The
increased coverage of fatty acid and lipid metabolism that is seen
in them is in large part due to the updated base reconstruction
used for the model’s reconstruction (i.e., using Recon 3 instead
of Recon 1). Additionally, when the iMSC1255 model was
constrained using the same metabolomic data sets as were used
to reconstruct the presented three new MSC models, the new
models (iMSC-E-1972, iMSC-O-1900 and iMSC-A-1972) were
better able to match the results of Meyer et al. (2018) compared
to iMSC1255 (Figure 4). This indicates that by specifically
constraining the models with transcriptomics data from various
differentiation lineages the models created are better able to show
the differences in metabolism between the different lineages.
Verification of Lineage Specific
Metabolic Functions
A good qualitative fit between known metabolic differences
between the three lineages studied and the relationships between
the predicted fluxes in the three new models was observed. Key
metabolic features, such as the production of ATP changing
in osteogenesis, are reflected in the differences between the
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models, indicative of a realistic reconstruction reflecting expected
biological behavior. Differences in amino acid metabolism,
ornithine and to a lesser extent glutamine and tryptophan,
are shown between osteogenesis and expansion in ways that
reflect known differences in metabolism during osteogenic
differentiation.
G6PDH expression is known to be key to producing NADPH
for fatty acid synthesis and overall activity of this enzyme is
greater in the adipogenic model than the other two cell lineage
models, an observation suggesting that these models reflect this
aspect of metabolism well. However, comments on the activity
of G6PDH in relation to this paper are complicated by the
reversibility of this reaction and the presence in the models of
multiple forms of this enzyme. In iMSC1255, the flux is only
predicted to be in the reverse direction, creating NADP not
NADPH. This does not agree with the previous consensus, our
models suggest a mix, specifically our adipogenic model favors
NADPH production in accordance with the literature (Park
et al., 2005; Melis et al., 2013; Lee et al., 2017; Meyer et al.,
2018). These contradictions might suggest that this may be either
premature or reflective of the limitations of measuring activity in
an isolated enzyme.
Overall, these results demonstrate that this key area of
metabolism is well reflected in the models which gives a
good ground for building the iMSC-O-1900 model into the
later and potentially more metabolically diverse later stages
of osteogenesis.
Observation of Main Metabolic
Differences Between the Models
The groups of metabolic reactions that are upregulated in
each of the lineages reflect the changes in function of cells
during expansion and differentiation. The metabolic subsystems
upregulated in expansion are varied, reflecting the necessity of
the cells for varied reaction activity to be able to produce cell
biomass, membranes, and nucleic acids in order to grow. On the
other hand, the changes in adipogenesis are more concentrated
around fatty acids and fatty acid synthesis. This is to be expected,
especially the increased activity of fatty acid synthesis, which
is a key feature of adipocytes. The areas of metabolism with
the most concentrated changes in osteogenesis is fatty acid
oxidation, which reflects increased oxidative metabolism in
the differentiating cells – a phenomenon previously reported
by multiple studies (Chen et al., 2008; Pattappa et al., 2011;
Buravkova et al., 2013; Shum et al., 2016). All of the cell lines show
changes to the exchange reaction activity, which may partially
be due to exchange reaction alterations that happen during the
model reconstruction process but since many of these observed
differences reflect actual measured differences this is unlikely
to be problematic.
Proposed Method to Increase
Osteogenesis
The results of the relaxation of reactions between adipogensis
or expansion and osteogenesis suggest that alterations in the
need for malate are changed, with either reduced uptake or
a switch to secretion being observed in both cases. Fatty acid
and lipids, particularly those involved in signaling (i.e., retinoic
acids and fatty acids) and those involved in cell membranes and
glycosylation (i.e., myelin_HS) are altered as well. These are key
metabolites for the rearrangement of cell membranes and trans-
membrane glycoproteins as well as cell signaling and therefore
seem plausible as metabolic markers of differentiation. One of the
reactions highlighted is the need to increase transport of citrate
from the extracellular space to the cytosol. It has been shown that
growing cells on citrate rich materials encourages osteogenesis
(Wang et al., 2013; Irizarry et al., 2017), this match with
the literature is encouraging. This discovery regarding citrate
in combination with the enrichment of the exchange/demand
reactions subsystem also suggests that other transporters may
be interesting targets for future investigation when it comes to
searching for new ways to increase osteogenesis of MSCs.
CONCLUSION
We present three new genome-scale metabolic models of
MSC metabolism, representing expansion, osteogenesis and
adipogenesis differentiation. These newly reconstructed models
are increased in scope compared to previous models of this
cell type both in terms of the coverage of multiple lineages
in models produced specifically for two new lineages and with
the models due to usage of a new and much improved base
human metabolic reconstruction (Recon3). We computed a
variety of metabolic phenotypes, demonstrating that the models
presented here accurately represent qualitative and quantitative
cellular characteristics and important differences between the cell
types. Having validated these models, we used them for model-
driven experimental design with the goal to optimize in vitro
osteogenesis. One of predicted solutions, the citrate transporter,
concurs with a previously identified target which encourages
further possibilities of similar predictions. Through the use of
mechanistic models such as are presented here, we provide a
blueprint for the application and engineering of regenerative
medicine therapies where promising therapeutics like MSCs can
be made more efficient and attainable.
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